Barbara Deptula serves as Executive at AMAG PHARMACEUTICALS INC., where they oversee executive responsibilities. Since joining the company, Barbara Deptula has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 16, 2019 involved receiving (via award) 8,116 shares valued at $0.
Barbara Deptula currently holds 26,354 shares of AMAG PHARMACEUTICALS INC. (AMAG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Deptula has been a net neutral trader of AMAG stock. They have purchased $0 and sold $0 worth of shares.
Barbara Deptula's most recent insider trade was on May 16, 2019, when they sold 8,116 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 18, 2017 | AMAG | $0 | Award | 4,545 | $N/A | Discretionary |
| May 19, 2016 | AMAG | $0 | Award | 4,768 | $N/A | Discretionary |
| May 21, 2015 | AMAG | $0 | Award | 1,322 | $N/A | Discretionary |
| May 22, 2014 | AMAG | $0 | Award | 2,300 | $N/A | Discretionary |
| Sep 6, 2013 | AMAG | $0 | Award | 1,725 | $N/A | Discretionary |